6th Targeted Protein Degradation Summit

Ensure your whole team stays connected and miles ahead of the curve with unmatched industry insights across early discovery, through the clinic and towards approval.

Spanning the full breadth of PROTAC and molecular glue clinical development, to unveiling next generation strategies including AbTACs, DUBTACs, bioPROTACs, ATACs, AUTOTACs and more, this meeting is your definitive opportunity to troubleshoot challenging problems and inspire new ideas with peers.

Whilst continuing to deliver breaking clinical updates first and foremost from the field’s key players; Nurix Therapeutics, C4 Therapeutics, Foghorn Therapeutics, Arvinas, and Kymera Therapeutics, this year we have added an additional discovery track, to cater for and support the rapidly expanding network of early-stage developers in the field.

Explore the brand new 2023 program here – https://ter.li/t0ygu7 

700+ Attendees | 100+ World Class Speakers | 10+ Hours of Networking | 6 Workshops | 4 Streams of Content | 3 Pre-Conference Deep-Dive Days | 1 Post-conference Focus Day